New Launch17 Jan 2025, 12:42 am
Bajaj Healthcare Secures Exclusive Rights for Magtein® Manufacturing, Marketing, and Sales in India
AI Summary
Bajaj Healthcare Limited has announced that it has received exclusive rights for manufacturing, distribution, and sales of the finished formulation of the Product Magnesium L Threonate (Magtein®) in India from the rights holder, Threotech LLC. The company will have the rights to manufacture, market, distribute, and co-market the product in the Indian market. Bajaj Healthcare Limited is already supplying the API Magnesium L Threonate (Magtein®) to the patent holder in the United States of America.
Key Highlights
- Bajaj Healthcare Limited has received exclusive rights for manufacturing, distribution, and sales of Magtein® in India.
- The company will have the rights to manufacture, market, distribute, and co-market the product in the Indian market.
- Bajaj Healthcare Limited is already supplying the API Magnesium L Threonate (Magtein®) to the patent holder in the United States of America.
- The brand Magtein® by Threotech LLC has a sales value of approx. USD 438 million.
- This development reaffirms Bajaj Healthcare Limited's position as a trusted partner to international clients.